Kosaka, Y., Tanino, H., Sengoku, N., Minatani, N., Kikuchi, M., Nishimiya, H., . . . Watanabe, M. (2015). Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy. Support Care Cancer.
Citación estilo ChicagoKosaka, Yoshimasa, et al. "Phase II Randomized, Controlled Trial of 1 day Versus 3 days of Dexamethasone Combined With Palonosetron and Aprepitant to Prevent Nausea and Vomiting in Japanese Breast Cancer Patients Receiving Anthracycline-based Chemotherapy." Support Care Cancer 2015.
Cita MLAKosaka, Yoshimasa, et al. "Phase II Randomized, Controlled Trial of 1 day Versus 3 days of Dexamethasone Combined With Palonosetron and Aprepitant to Prevent Nausea and Vomiting in Japanese Breast Cancer Patients Receiving Anthracycline-based Chemotherapy." Support Care Cancer 2015.